Business Context and Reporting Period
This Form 8-K was filed by TherapeuticsMD, Inc. (Nasdaq: TXMD) on August 23, 2022. The report discloses a corporate governance change involving the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It references a prior capital raise but does not detail the company's current financial position within this specific document.
Material Changes
- Board Expansion: The Board of Directors increased its size from eight to nine members.
- Director Appointment: Mr. Justin Roberts was appointed as a director effective August 23, 2022, to fill the newly created vacancy.
- Term: Mr. Roberts will serve until the 2022 Annual Meeting of Stockholders or until a successor is elected/appointed.
Management Commentary, Risks, and Unusual Items
- Compensation: While entitled to standard non-employee director compensation, Mr. Roberts has elected not to receive any compensation for his service at this time.
- Related Party Transaction: Mr. Roberts is a Partner at Rubric Capital Management LP. On July 29, 2022, the Company sold 15,000 shares of Series A Preferred Stock and 565,000 shares of common stock to Rubric for an aggregate price of $15 million.
- Committee Assignments: Mr. Roberts has not been appointed to any Board committees at this time.
- Conflict of Interest: The filing states there are no other arrangements regarding his appointment and no other material transactions involving Mr. Roberts exceeding $120,000 since the beginning of the last fiscal year.
Investor Verification Checklist
- Verify the details of the $15 million private placement with Rubric Capital Management LP referenced in the August 1, 2022, Form 8-K.
- Review the "Director Compensation" section in the Company's Amendment No. 1 to Form 10-K (filed April 29, 2022) to understand the standard compensation structure Mr. Roberts declined.
- Monitor the 2022 Annual Meeting of Stockholders for the election status of Mr. Roberts.
- Confirm if Mr. Roberts will be assigned to any Board committees in future filings.